B0252025Cancer Immunology Research 13 (9_Supplement), B025-B025, 2025
Abstract B025: An agentic platform for designing cancer immunotherapies: From automated variant interpretation to in silico therapeutic validation
F Kiani, R Nayeem
This link is not a direct PDF file, so it cannot be embedded. Open it in a new tab instead.
Open linked resourceAbstract B025: An agentic platform for designing cancer immunotherapies: From automated variant interpretation to in silico therapeutic validation
CrisPRO presents an agentic workflow that connects variant interpretation, therapeutic hypothesis generation, and in silico validation for cancer immunotherapy design. The platform automates evidence synthesis across genomic and pathway layers.
F Kiani, R Nayeem
Cancer Immunology Research 13 (9_Supplement), B025-B025, 2025
Published abstract: https://aacrjournals.org/cancerimmunolres/article/13/9_Supplement/B025/765414/Abstract-B025-An-agentic-platform-for-designing